DFO-ATEZOLIZUMAB ZR-89
UNII 5V432W4W6B

Substance Identification & Data

This profile provides standardized clinical and technical data for Dfo-atezolizumab Zr-89, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5V432W4W6B.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
5V432W4W6B
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
DFO-ATEZOLIZUMAB ZR-89
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C122404
National Cancer Institute reference terminology for clinical and research data.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Dfo-atezolizumab Zr-89. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

(89ZR)ZR-DFO-ATZ
89ZR-DFO-ATEZOLIZUMAB
DFO-ATEZOLIZUMAB ZR-89

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus